IMW 2019 | Using immunopaths to image residual disease

Ola Landgren

Ola Landgren, MD, PhD, of Memorial Sloan Kettering Cancer Center, New York, NY, discusses his research into immunopaths and describes the method by which he was successful in imaging potential residual disease that would not otherwise have been visible using blood tests or biopsies. This interview was recorded at the international myeloma workshop (IMW) 2019, in Boston, MA.

Share this video